X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1043) 1043
Book Review (203) 203
Publication (54) 54
Book / eBook (17) 17
Book Chapter (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (926) 926
humans (860) 860
female (548) 548
male (524) 524
middle aged (412) 412
oncology (409) 409
adult (348) 348
hematology (324) 324
aged (311) 311
transplantation (257) 257
infusions, intravenous (247) 247
chemotherapy (238) 238
treatment outcome (236) 236
melphalan - administration & dosage (210) 210
injections, intravenous (194) 194
melphalan (182) 182
cancer (168) 168
immunology (167) 167
multiple myeloma - drug therapy (156) 156
multiple myeloma (152) 152
stem-cell transplantation (152) 152
therapy (150) 150
antineoplastic combined chemotherapy protocols - therapeutic use (148) 148
stem cells (142) 142
bone-marrow-transplantation (141) 141
pharmacology & pharmacy (135) 135
adolescent (133) 133
child (127) 127
hematopoietic stem cell transplantation (127) 127
care and treatment (126) 126
intravenous melphalan (126) 126
pharmacokinetics (121) 121
hematopoietic stem cells (113) 113
retrospective studies (111) 111
animals (110) 110
child, preschool (110) 110
dose-response relationship, drug (105) 105
transplantation, autologous (105) 105
antineoplastic agents - administration & dosage (99) 99
drug administration schedule (97) 97
medicine & public health (96) 96
stem cell transplantation (95) 95
cyclophosphamide (94) 94
busulfan (87) 87
melphalan - therapeutic use (87) 87
health aspects (86) 86
survival analysis (86) 86
children (85) 85
busulfan - administration & dosage (84) 84
melphalan - adverse effects (84) 84
transplantation conditioning - methods (83) 83
disease-free survival (82) 82
multiple-myeloma (82) 82
combined modality therapy (81) 81
dosage and administration (81) 81
infant (81) 81
survival (80) 80
multiple myeloma - therapy (79) 79
hematopoietic stem cell transplantation - methods (77) 77
intravenous administration (77) 77
administration, oral (76) 76
analysis (76) 76
antineoplastic combined chemotherapy protocols - administration & dosage (76) 76
research (75) 75
antineoplastic agents - therapeutic use (73) 73
follow-up studies (73) 73
antineoplastic agents, alkylating - administration & dosage (72) 72
bone-marrow transplantation (72) 72
survival rate (72) 72
antineoplastic combined chemotherapy protocols - adverse effects (71) 71
toxicity (71) 71
immunoglobulins, intravenous - therapeutic use (70) 70
abridged index medicus (69) 69
cyclophosphamide - administration & dosage (69) 69
aged, 80 and over (67) 67
hematology, oncology and palliative medicine (67) 67
risk factors (66) 66
bortezomib (63) 63
antineoplastic agents - adverse effects (62) 62
prognosis (62) 62
neoplasms - drug therapy (60) 60
time factors (60) 60
hematopoietic stem cell transplantation - adverse effects (59) 59
transplantation, homologous (59) 59
high-dose melphalan (57) 57
intravenous busulfan (57) 57
daily intravenous busulfan (56) 56
pediatrics (56) 56
recurrence (56) 56
drug therapy (55) 55
young adult (55) 55
patients (54) 54
bone marrow transplantation (53) 53
versus-host-disease (52) 52
leukemia (50) 50
melphalan - pharmacokinetics (49) 49
remission induction (49) 49
transplantation conditioning (49) 49
trial (49) 49
internal medicine (48) 48
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Gerstein Science - Missing (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Mt Sinai Hospital - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Withdrawn (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1023) 1023
German (12) 12
French (10) 10
Russian (7) 7
Japanese (5) 5
Spanish (4) 4
Italian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 500 - 514
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 07/2016, Volume 82, Issue 1, pp. 149 - 159
Journal Article
Journal Article
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ISSN 1083-8791, 01/2013, Volume 19, Issue 1, pp. 69 - 74
Melphalan 200 mg/m(2) (MEL200) is the standard conditioning regimen administered to newly diagnosed patients with multiple myeloma (MM) undergoing autologous... 
SINGLE | Intravenous busulfan | Autologous transplantation | CYCLOPHOSPHAMIDE | Multiple myeloma | IMMUNOLOGY | TRANSPLANTATION | INTERGROUPE FRANCOPHONE | PHASE-II TRIAL | PROGNOSTIC-FACTOR | 200 MG/M | THERAPY | Melphalan | SPANISH REGISTRY | HIGH-DOSE MELPHALAN | HEMATOLOGY | GENETIC ABNORMALITIES
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 05/2018, Volume 53, Issue 5, pp. 591 - 599
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 05/2018, Volume 24, Issue 5, pp. 923 - 929
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 08/2016, Volume 63, Issue 8, pp. 1349 - 1356
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 10/2015, Volume 62, Issue 10, pp. 1739 - 1746
Journal Article